NCT04594252View on ClinicalTrials.gov

Copper Balance in Healthy Participants Administered ALXN1840

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

November 18, 2020

Study Completion Date

November 18, 2020

Conditions
Healthy
Interventions
DRUG

ALXN1840

Administered orally as tablets.

Trial Locations (1)

Unknown

Clinical Study Site, London

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY